Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bleyer

Showing results (541-550 of 664) with videos related to

Pageof 67
Sort By:
Frontiers in Medicine|October 4, 2021
Sexual Dysfunction in Patients With Urinary Bladder Stones but no Bladder Outlet ObstructionZhi-Cheng Gong, Zhi-Liang Wu, Yao-An Wen, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|December 24, 1997
National cancer clinical trials: children have equal access; adolescents do notW A Bleyer, H Tejeda, S B Murphy, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|March 8, 2018
Identification of a novel UMOD mutation (c.163G>A) in a Brazilian family with autosomal dominant tubulointerstitial kidney diseaseL B Lopes, C C Abreu, C F Souza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study GroupW A Bleyer, H N Sather, H J Nickerson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106P S Gaynon, P G Steinherz, W A Bleyer, et al.
Lancet (London, England)|October 22, 1988
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study GroupP S Gaynon, P G Steinherz, W A Bleyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapyT W Pendergrass, J M Milstein, J R Geyer, et al.
Kidney International|March 5, 2015
Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus reportKai-Uwe Eckardt, Seth L Alper, Corinne Antignac, et al.
The Journal of Experimental Medicine|August 4, 2010
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cellsYenkel Grinberg-Bleyer, Audrey Baeyens, Sylvaine You, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
MANF Clears Mutant Uromodulin in Human Kidney Organoids of Autosomal Dominant Tubulointerstitial Kidney DiseaseChenjian Gu, Yili Fang, Yixuan Wang, et al.
Pageof 67

Showing results (541-550 of 664) with videos related to

Sort By:
Pageof 67
Frontiers in Medicine|October 4, 2021
Sexual Dysfunction in Patients With Urinary Bladder Stones but no Bladder Outlet ObstructionZhi-Cheng Gong, Zhi-Liang Wu, Yao-An Wen, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|December 24, 1997
National cancer clinical trials: children have equal access; adolescents do notW A Bleyer, H Tejeda, S B Murphy, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|March 8, 2018
Identification of a novel UMOD mutation (c.163G>A) in a Brazilian family with autosomal dominant tubulointerstitial kidney diseaseL B Lopes, C C Abreu, C F Souza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study GroupW A Bleyer, H N Sather, H J Nickerson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106P S Gaynon, P G Steinherz, W A Bleyer, et al.
Lancet (London, England)|October 22, 1988
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study GroupP S Gaynon, P G Steinherz, W A Bleyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapyT W Pendergrass, J M Milstein, J R Geyer, et al.
Kidney International|March 5, 2015
Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus reportKai-Uwe Eckardt, Seth L Alper, Corinne Antignac, et al.
The Journal of Experimental Medicine|August 4, 2010
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cellsYenkel Grinberg-Bleyer, Audrey Baeyens, Sylvaine You, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
MANF Clears Mutant Uromodulin in Human Kidney Organoids of Autosomal Dominant Tubulointerstitial Kidney DiseaseChenjian Gu, Yili Fang, Yixuan Wang, et al.
Pageof 67